Meridian Financial Partners LLC Bristol Myers Squibb CO Transaction History

Meridian Financial Partners LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 29, 2022	BUY	$72.62 - $79.98 $207,838 - $228,902	2,862 New	2,862 $214,000
Q1 2021 Apr 21, 2021	SELL	$59.34 - $66.74 $596,901 - $671,337	-10,059 Closed	0 $0
Q4 2020 Jan 21, 2021	SELL	$57.74 - $65.43 $23,153 - $26,237	-401 Reduced 3.83%	10,059 $666,000
Q3 2020 Nov 02, 2020	BUY	$57.43 - $63.64 $1,033 - $1,145	18 Added 0.17%	10,460 $624,000
Q2 2020 Jul 21, 2020	BUY	$54.82 - $64.09 $192,308 - $224,827	3,508 Added 50.59%	10,442 $604,000
Q1 2020 Apr 21, 2020	BUY	$46.4 - $67.43 $17,724 - $25,758	382 Added 5.83%	6,934 $420,000
Q4 2019 Jan 13, 2020	SELL	$49.21 - $64.19 $10,776 - $14,057	-219 Reduced 3.23%	6,552 $418,000
Q3 2019 Oct 07, 2019	BUY	$42.77 - $50.71 $24,421 - $28,955	571 Added 9.21%	6,771 $333,000
Q2 2019 Jul 19, 2019	BUY	$44.62 - $49.34 $28,512 - $31,528	639 Added 11.49%	6,200 $285,000
Q1 2019 May 01, 2019	BUY	$45.12 - $53.8 $7,941 - $9,468	176 Added 3.27%	5,561 $255,000
Q4 2018 Jan 16, 2019	BUY	$48.76 - $63.23 $262,572 - $340,493	5,385 New	5,385 $280,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Meridian Financial Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Meridian Financial Partners LLC with notifications on news.